These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The rapid discovery of engineered antibodies. Wang M; He M IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332 [TBL] [Abstract][Full Text] [Related]
27. Phage Display Technology as a Powerful Platform for Antibody Drug Discovery. Nagano K; Tsutsumi Y Viruses; 2021 Jan; 13(2):. PubMed ID: 33504115 [TBL] [Abstract][Full Text] [Related]
28. Antibody engineering and modification technologies. Filpula D Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589 [TBL] [Abstract][Full Text] [Related]
29. Recombinant Antibody Selections by Combining Phage and Yeast Display. Ferrara F; Soluri MF; Sblattero D Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479 [TBL] [Abstract][Full Text] [Related]
30. Mammalian cell display and somatic hypermutation in vitro for human antibody discovery. King DJ; Bowers PM; Kehry MR; Horlick RA Curr Drug Discov Technol; 2014 Mar; 11(1):56-64. PubMed ID: 23978037 [TBL] [Abstract][Full Text] [Related]
31. Construction of human antibody gene libraries and selection of antibodies by phage display. Frenzel A; Kügler J; Wilke S; Schirrmann T; Hust M Methods Mol Biol; 2014; 1060():215-43. PubMed ID: 24037844 [TBL] [Abstract][Full Text] [Related]
32. Protein and Antibody Engineering by Phage Display. Frei JC; Lai JR Methods Enzymol; 2016; 580():45-87. PubMed ID: 27586328 [TBL] [Abstract][Full Text] [Related]
33. [Progression and direction of humanized antibody research]. Lin Y; Yan XY Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):1-5. PubMed ID: 16108479 [TBL] [Abstract][Full Text] [Related]
34. Affinity maturation: highlights in the application of in vitro strategies for the directed evolution of antibodies. Chan DTY; Groves MAT Emerg Top Life Sci; 2021 Nov; 5(5):601-608. PubMed ID: 33660765 [TBL] [Abstract][Full Text] [Related]
35. Human antibody libraries: a race to engineer and explore a larger diversity. Mondon P; Dubreuil O; Bouayadi K; Kharrat H Front Biosci; 2008 Jan; 13():1117-29. PubMed ID: 17981617 [TBL] [Abstract][Full Text] [Related]
36. Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues. Kaleli NE; Karadag M; Kalyoncu S Proteins; 2019 Jul; 87(7):607-618. PubMed ID: 30883916 [TBL] [Abstract][Full Text] [Related]
37. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen. Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791 [TBL] [Abstract][Full Text] [Related]